Literature DB >> 21605945

Physician beliefs and practices for adjuvant and salvage radiation therapy after prostatectomy.

Timothy N Showalter1, Nitin Ohri, Kristopher G Teti, Kathleen A Foley, Scott W Keith, Edouard J Trabulsi, Costas D Lallas, Adam P Dicker, Jean Hoffman-Censits, Laura T Pizzi, Leonard G Gomella.   

Abstract

PURPOSE: Despite results of randomized trials that support adjuvant radiation therapy (RT) after radical prostatectomy (RP) for prostate cancer with adverse pathologic features (APF), many clinicians favor selective use of salvage RT. This survey was conducted to evaluate the beliefs and practices of radiation oncologists (RO) and urologists (U) regarding RT after RP. METHODS AND MATERIALS: We designed a Web-based survey of post-RP RT beliefs and policies. Survey invitations were e-mailed to a list of 926 RO and 591 U. APF were defined as extracapsular extension, seminal vesicle invasion, or positive surgical margin. Differences between U and RO in adjuvant RT recommendations were evaluated by comparative statistics. Multivariate analyses were performed to evaluate factors predictive of adjuvant RT recommendation.
RESULTS: Analyzable surveys were completed by 218 RO and 92 U (overallresponse rate, 20%). Adjuvant RT was recommended based on APF by 68% of respondents (78% RO, 44% U, p <0.001). U were less likely than RO to agree that adjuvant RT improves survival and/or biochemical control (p < 0.0001). PSA thresholds for salvage RT were higher among U than RO (p < 0.001). Predicted rates of erectile dysfunction due to RT were higher among U than RO (p <0.001). On multivariate analysis, respondent specialty was the only predictor of adjuvant RT recommendations.
CONCLUSIONS: U are less likely than RO to recommend adjuvant RT. Future research efforts should focus on defining the toxicities of post-RP RT and on identifying the subgroups of patients who will benefit from adjuvant vs. selective salvage RT.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21605945      PMCID: PMC3879023          DOI: 10.1016/j.ijrobp.2011.04.003

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  27 in total

Review 1.  Advances in image-guided radiation therapy.

Authors:  Laura A Dawson; David A Jaffray
Journal:  J Clin Oncol       Date:  2007-03-10       Impact factor: 44.544

Review 2.  Innovations in image-guided radiotherapy.

Authors:  Dirk Verellen; Mark De Ridder; Nadine Linthout; Koen Tournel; Guy Soete; Guy Storme
Journal:  Nat Rev Cancer       Date:  2007-12       Impact factor: 60.716

3.  Adjuvant radiotherapy use and patterns of care analysis for margin-positive prostate adenocarcinoma with extracapsular extension: postprostatectomy adjuvant radiotherapy: a SEER analysis.

Authors:  Amol J Ghia; Dennis C Shrieve; Jonathan D Tward
Journal:  Urology       Date:  2010-08-14       Impact factor: 2.649

4.  Time trends and local variation in primary treatment of localized prostate cancer.

Authors:  Matthew R Cooperberg; Jeanette M Broering; Peter R Carroll
Journal:  J Clin Oncol       Date:  2010-02-01       Impact factor: 44.544

5.  Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy.

Authors:  Bruce J Trock; Misop Han; Stephen J Freedland; Elizabeth B Humphreys; Theodore L DeWeese; Alan W Partin; Patrick C Walsh
Journal:  JAMA       Date:  2008-06-18       Impact factor: 56.272

6.  Toxicity analysis of postoperative image-guided intensity-modulated radiotherapy for prostate cancer.

Authors:  Sameer K Nath; Ajay P Sandhu; Brent S Rose; Daniel R Simpson; Polly D Nobiensky; Jia-Zhu Wang; Fred Millard; Christopher J Kane; J Kellogg Parsons; Arno J Mundt
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-11-24       Impact factor: 7.038

7.  Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95.

Authors:  Thomas Wiegel; Dirk Bottke; Ursula Steiner; Alessandra Siegmann; Reinhard Golz; Stephan Störkel; Norman Willich; Axel Semjonow; Rainer Souchon; Michael Stöckle; Christian Rübe; Lothar Weissbach; Peter Althaus; Udo Rebmann; Tilman Kälble; Horst Jürgen Feldmann; Manfred Wirth; Axel Hinke; Wolfgang Hinkelbein; Kurt Miller
Journal:  J Clin Oncol       Date:  2009-05-11       Impact factor: 44.544

8.  Adjuvant high-dose intensity-modulated radiotherapy after radical prostatectomy for prostate cancer: clinical results in 104 patients.

Authors:  Piet Ost; Valérie Fonteyne; Geert Villeirs; Nicolaas Lumen; Willem Oosterlinck; Gert De Meerleer
Journal:  Eur Urol       Date:  2009-05-29       Impact factor: 20.096

9.  Salvage intensity-modulated radiotherapy for rising PSA after radical prostatectomy.

Authors:  Gert De Meerleer; Valérie Fonteyne; Sabine Meersschout; Caroline Van den Broecke; Geert Villeirs; Nicolaas Lumen; Piet Ost; Katrien Vandecasteele; Wilfried De Neve
Journal:  Radiother Oncol       Date:  2008-09-02       Impact factor: 6.280

10.  Prostate cancer.

Authors:  David F Penson; June M Chan
Journal:  J Urol       Date:  2007-06       Impact factor: 7.450

View more
  16 in total

Review 1.  Can early implementation of salvage radiotherapy for prostate cancer improve the therapeutic ratio? A systematic review and regression meta-analysis with radiobiological modelling.

Authors:  Nitin Ohri; Adam P Dicker; Edouard J Trabulsi; Timothy N Showalter
Journal:  Eur J Cancer       Date:  2011-09-22       Impact factor: 9.162

2.  Management of prostate cancer patients following radiation therapy after radical surgery referred from urology to radiation oncology departments in Spain.

Authors:  A Gómez Caamaño; A Zapatero; J López Torrecilla; X Maldonado
Journal:  Clin Transl Oncol       Date:  2015-11-30       Impact factor: 3.405

3.  Opinions from the experts: exploring what prostate cancer patients should know about post-operative radiotherapy.

Authors:  Laura D'Alimonte; Kaitlin Koo; Emily Chen; Deb Feldman-Stewart; Arlene Court; Margaret Fitch; Lisa Di Prospero; John Maamoun; Alex Kiss; Ewa Szumacher
Journal:  J Cancer Educ       Date:  2013-09       Impact factor: 2.037

4.  Postoperative biochemical recurrence of pathologically localized high-grade prostate cancer in adjuvant treatment-naïve patients.

Authors:  Ji Eun Heo; Jee Soo Park; Jong Soo Lee; Jongchan Kim; Won Sik Jang; Nam Hoon Cho; Koon Ho Rha; Young Deuk Choi; Sung Joon Hong; Won Sik Ham
Journal:  J Cancer Res Clin Oncol       Date:  2019-10-14       Impact factor: 4.553

5.  Salvage radiotherapy for prostate cancer: Finding a way forward using radiobiological modeling.

Authors:  Nitin Ohri; Xinglei Shen; Robert B Den; Adam P Dicker; Edouard J Trabulsi; Timothy N Showalter
Journal:  Cancer Biol Ther       Date:  2012-09-06       Impact factor: 4.742

6.  Patterns of Care Related to Post-Operative Radiotherapy for Patients with Prostate Cancer among Canadian Radiation Oncologists and Urologists.

Authors:  Bonnie Bristow; Mohammed Aldehaim; Katija Bonin; Candice Chee Ka Lam; Stephanie J Wan; Xingshan Cao; Ewa Szumacher
Journal:  J Cancer Educ       Date:  2018-12       Impact factor: 2.037

7.  Adjuvant and salvage radiation therapy after prostatectomy: investigating beliefs and practices of radiation oncologists.

Authors:  Marco Lupattelli; Matthew Alcusky; Cynthia Aristei; Rita Bellavita; Barbara A Jereczek-Fossa; John McAna; Timothy N Showalter; Vittorio Maio
Journal:  Br J Radiol       Date:  2015-09-22       Impact factor: 3.039

8.  Evaluating the clinical impact of a genomic classifier in prostate cancer using individualized decision analysis.

Authors:  Jennifer Mason Lobo; Adam P Dicker; Christine Buerki; Elai Daviconi; R Jeffrey Karnes; Robert B Jenkins; Nirav Patel; Robert B Den; Timothy N Showalter
Journal:  PLoS One       Date:  2015-04-02       Impact factor: 3.240

9.  Radiation therapy after radical prostatectomy for prostate cancer: evaluation of complications and influence of radiation timing on outcomes in a large, population-based cohort.

Authors:  Sarah E Hegarty; Terry Hyslop; Adam P Dicker; Timothy N Showalter
Journal:  PLoS One       Date:  2015-02-23       Impact factor: 3.240

10.  Treatment-related complications of radiation therapy after radical prostatectomy: comparative effectiveness of intensity-modulated versus conformal radiation therapy.

Authors:  Edwin F Crandley; Sarah E Hegarty; Terry Hyslop; David D Wilson; Adam P Dicker; Timothy N Showalter
Journal:  Cancer Med       Date:  2014-02-12       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.